Frazier Life Sciences — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
BiotechWestlake Village, US
Alexander Asam(Director)Ricky Sun(Director)Jonathan Silverstein(Director)Todd Franklin Watanabe(Executive Officer, Director)
Board seatPatrick HeronDaniel Estes· per SEC Form D · $94.5M raise · filed Oct 2019
Passage Bio is a company focused on developing treatments for central nervous system (CNS) diseases, with an emphasis on neurodegenerative conditions.
BiotechHealthtechPhiladelphia, US
Carl Gordon(Director)Tadataka Yamada(Executive Officer, Director, Promoter)Saqib Islam(Director)Thomas Street Address 1 Woiwode(Director)Stephen Squinto(Executive Officer, Director)
Board seatPatrick Heron· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.